Skip to content
10-Q

Quarterly Report

MARINUS PHARMACEUTICALS, INC.

0001558370-24-011982

← back to feed
Filed
Aug 13, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 7, 2024 55.08M sh
Shares Diluted Q2 2024 · Jun 30, 2024 57.06M sh
Shares Diluted Q2 2024 · Jun 30, 2024 56.96M sh
Shares Diluted Q2 2024 · Jun 30, 2023 52.55M sh
Shares Diluted Q2 2024 · Jun 30, 2023 52.16M sh
Capex Q2 2024 · Jun 30, 2024 $38K
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$68.3M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$65.84M
Long Term Debt Q2 2024 · Jun 30, 2024 $58.13M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $64.68M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $120.57M
Stockholders Equity Q2 2024 · Jun 30, 2024 −$47.35M
Stockholders Equity Q2 2024 · Mar 31, 2024 −$16.43M
Stockholders Equity Q2 2024 · Dec 31, 2023 $16.77M
Stockholders Equity Q2 2024 · Jun 30, 2023 $57.34M
Stockholders Equity Q2 2024 · Mar 31, 2023 $85.09M
Stockholders Equity Q2 2024 · Dec 31, 2022 $116M
Current Liabilities Q2 2024 · Jun 30, 2024 $35.87M
Current Liabilities Q2 2024 · Dec 31, 2023 $40.62M
Total Liabilities Q2 2024 · Jun 30, 2024 $134.43M
Total Liabilities Q2 2024 · Dec 31, 2023 $154.14M
Current Assets Q2 2024 · Jun 30, 2024 $81.88M
Current Assets Q2 2024 · Dec 31, 2023 $165.25M
Total Assets Q2 2024 · Jun 30, 2024 $87.08M
Total Assets Q2 2024 · Dec 31, 2023 $170.91M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.63
Eps Diluted Q2 2024 · Jun 30, 2024 −$1.31
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.61
Eps Diluted Q2 2024 · Jun 30, 2023 −$1.28
Eps Basic Q2 2024 · Jun 30, 2024 −$0.63
Eps Basic Q2 2024 · Jun 30, 2024 −$1.31
Eps Basic Q2 2024 · Jun 30, 2023 −$0.61
Eps Basic Q2 2024 · Jun 30, 2023 −$1.28
Sga Expense Q2 2024 · Jun 30, 2024 $16.71M
Sga Expense Q2 2024 · Jun 30, 2024 $35.34M
Sga Expense Q2 2024 · Jun 30, 2023 $15.72M
Sga Expense Q2 2024 · Jun 30, 2023 $30.93M
Rd Expense Q2 2024 · Jun 30, 2024 $20.9M
Rd Expense Q2 2024 · Jun 30, 2024 $45.02M
Rd Expense Q2 2024 · Jun 30, 2023 $21.41M
Rd Expense Q2 2024 · Jun 30, 2023 $49.35M
Net Income Q2 2024 · Jun 30, 2024 −$35.83M
Net Income Q2 2024 · Jun 30, 2024 −$74.5M
Net Income Q2 2024 · Mar 31, 2024 −$38.67M
Net Income Q2 2024 · Jun 30, 2023 −$31.93M
Net Income Q2 2024 · Mar 31, 2023 −$34.73M
Operating Income Q2 2024 · Jun 30, 2024 −$32.24M
Operating Income Q2 2024 · Jun 30, 2024 −$68.06M
Operating Income Q2 2024 · Jun 30, 2023 −$31.44M
Operating Income Q2 2024 · Jun 30, 2023 −$64.4M